Specially packaged DNA secreted by tumor cells can trigger an immune response that inhibits the metastatic spread of the ...

The primary endpoint of overall survival was missed in the SKYSCRAPER-01 study assessing tiragolumab plus Tecentriq in some ...

At the conference, AstraZeneca and Daiichi Sankyo will present their case for Dato-DXd in NSCLC, while BioNTech and Merus ...

Luye Pharma Group (HK:2186) has released an update. Luye Pharma Group has received approval from China’s National Medical Products Administration ...

Cost-effectiveness agency NICE has recommended NHS use of the therapy – called Kimmtrak (tebentafusp) – for the treatment of ...

Novocure’s TTFields therapy combined with chemo improved overall survival by 16.2 months compared to 14.16 months with chemo ...

The FDA granted approval to nilotinib (Danziten) on November 14, 2024, for the treatment of adult patients with newly ...